Relationship of diabetic macular oedema with glycosylated haemoglobin

Eye

Volumn 23, Issue 6, 2009, Pages 1360-1363

  Chou, T H ^a,b   Wu, P C ^a,b   Kuo, J Z C ^a,b   Lai, C H ^a,b,c   Kuo, C N ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Diabetic macular oedema; Glycosylated haemoglobin; Optical coherence tomography

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DIABETES CONTROL; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE DURATION; EARLY DIAGNOSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; RETINA FOVEA; RETROSPECTIVE STUDY; RISK REDUCTION; THICKNESS; UNIVARIATE ANALYSIS;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; DIABETIC RETINOPATHY; FEMALE; FOVEA CENTRALIS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 67650689608     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.279     Document Type: Article

References (11)

1. Diabetic retinopathy. American diabetes association. Diabetes Care 1998; 21:157-159.
2. Hee MR, Puliafito CA, Wong C, Duker JS, Reichel E, Rutledge B et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 1995; 113:1019-1029.
3. The relationship of glycemic exposure (HbA1c) to the risk of development progression of retinopathy in the diabetes control: and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1995; 44:968-983.
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK prospective diabetes study (UKPDS) group. Lancet 1998; 352:837-853.
5. Browning DJ, McOwen MD, Bowen Jr RM, O'Marah TL. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology 2004; 111:712-715.
6. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001; 358:221-229.
7. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes mondiale (DiaMond) project group. Diabetes Care 2000; 23:1516-1526.
8. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The wisconsin epidemiologic study of diabetic retinopathy. XV. The longterm incidence of macular edema. Ophthalmology 1995; 102:7-16.
9. Moreira RO, Trujillo FR, Meirelles RM, Ellinger VC, Zagury L. Use of optical coherence tomography (OCT) and indirect ophthalmoscopy in the diagnosis of macular edema in diabetic patients. Int Ophthalmol 2001; 24:331-336.
10. Hee MR, Puliafito CA, Duker JS, Reichel E, Coker JG, Wilkins JR et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998; 105:360-370.
11. Sakata K, Funatsu H, Harino S, Noma H, Hori S. Relationship of macular microcirculation and retinal thickness with visual acuity in diabetic macular edema. Ophthalmology 2007; 114:2061-2069.